|
1
|
Schorn VJ and Miles BA: Laryngeal squamous
cell carcinoma. ENT Board Prep. Lin F and Patel Z: Springer; New
York: pp. 227–233. 2014, View Article : Google Scholar
|
|
2
|
Almadori G, Bussu F, Cadoni G, Galli J,
Paludetti G and Maurizi M: Molecular markers in laryngeal squamous
cell carcinoma: towards an integrated clinicobiological approach.
Eur J Cancer. 41:683–693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Järvinen AK, Autio R, Haapa-Paananen S, et
al: Identification of target genes in laryngeal squamous cell
carcinoma by high-resolution copy number and gene expression
microarray analyses. Oncogene. 25:6997–7008. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gajecka M, Rydzanicz M, Jaskula-Sztul R,
Kujawski M, Szyfter W and Szyfter K: CYP1A1, CYP2D6, CYP2E1, NAT2,
GSTM1 and GSTT1 polymorphisms or their combinations are associated
with the increased risk of the laryngeal squamous cell carcinoma.
Mutat Res. 574:112–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ogino T, Shigyo H, Ishii H, et al: HLA
class I antigen down-regulation in primary laryngeal squamous cell
carcinoma lesions as a poor prognostic marker. Cancer Res.
66:9281–9289. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Celetti A, Testa D, Staibano S, et al:
Overexpression of the cytokine osteopontin identifies aggressive
laryngeal squamous cell carcinomas and enhances carcinoma cell
proliferation and invasiveness. Clin Cancer Res. 11:8019–8027.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar
|
|
8
|
Liu M, Wu H, Liu T, et al: Regulation of
the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Cell Res. 19:828–837. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bian K, Fan J, Zhang X, et al:
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal
carcinoma cells by directly targeting survivin. FEBS Lett.
586:804–809. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Long XB, Sun GB, Hu S, et al: Let-7a
microRNA functions as a potential tumor suppressor in human
laryngeal cancer. Oncol Rep. 22:1189–1195. 2009.PubMed/NCBI
|
|
11
|
Wu H, Liu T, Wang R, et al: MicroRNA-16
targets zyxin and promotes cell motility in human laryngeal
carcinoma cell line HEp-2. IUBMB Life. 63:101–108. 2011.PubMed/NCBI
|
|
12
|
Cai KM, Bao XL, Kong XH, et al:
Hsa-miR-34c suppresses growth and invasion of human laryngeal
carcinoma cells via targeting c-Met. Int J Mol Med. 25:565–571.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lian M, Fang J, Han D, et al: Microarray
gene expression analysis of tumorigenesis and regional lymph node
metastasis in laryngeal squamous cell carcinoma. PLoS One.
8:e848542013. View Article : Google Scholar
|
|
14
|
Diboun I, Wernisch L, Orengo CA and
Koltzenburg M: Microarray analysis after RNA amplification can
detect pronounced differences in gene expression using limma. BMC
Genomics. 7:2522006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang DW, Sherman BT, Tan Q, et al: The
DAVID gene functional classification tool: a novel biological
module-centric algorithm to functionally analyze large gene lists.
Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aoki-Kinoshita KF and Kanehisa M: Gene
annotation and pathway mapping in KEGG. Methods Mol Biol.
396:71–91. 2007.PubMed/NCBI
|
|
17
|
Hunter S, Jones P, Mitchell A, et al:
InterPro in 2011: new developments in the family and domain
prediction database. Nucleic Acids Res. 40:D306–D312. 2012.
View Article : Google Scholar :
|
|
18
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: a database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shannon P, Markiel A, Ozier O, et al:
Cytoscape: a software environment for integrated models of
biomolecular interaction networks. Genome Res. 13:2498–2504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nepusz T, Yu H and Paccanaro A: Detecting
overlapping protein complexes in protein-protein interaction
networks. Nat Methods. 9:471–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
an integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kastan MB and Bartek J: Cell-cycle
checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai K, Luo Y and Li L: Expression of MCM2
protein and its biological characteristic in human laryngeal
squamous cell carcinoma. J Acta Academiae Medicinae Jiangxi.
3:58–60. 2008.
|
|
25
|
Sherr CJ: G1 phase progression: cycling on
cue. J Cell. 79:551–555. 1994. View Article : Google Scholar
|
|
26
|
Dong Y, Sui L, Sugimoto K, Tai Y and
Tokuda M: Cyclin D1. CDK4 complex, a possible critical factor for
cell proliferation and prognosis in laryngeal squamous cell
carcinomas. Int J Cancer. 95:209–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Freeman A, Morris LS, Mills AD, et al:
Minichromosome maintenance proteins as biological markers of
dysplasia and malignancy. Clin Cancer Res. 5:2121–2132.
1999.PubMed/NCBI
|
|
28
|
Chatrath P, Scott IS, Morris LS, et al:
Aberrant expression of minichromosome maintenance protein-2 and
Ki67 in laryngeal squamous epithelial lesions. Br J Cancer.
89:1048–1054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Torres-Rendon A, Roy S, Craig G and
Speight P: Expression of Mcm2, geminin and Ki67 in normal oral
mucosa, oral epithelial dysplasias and their corresponding
squamous-cell carcinomas. Br J Cancer. 100:1128–1134. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mishra R: Glycogen synthase kinase 3 beta:
can it be a target for oral cancer. Mol Cancer. 9:1442010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Almond JB and Cohen GM: The proteasome: a
novel target for cancer chemotherapy. Leukemia. 16:433–443. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Orlowski RZ and Kuhn DJ: Proteasome
inhibitors in cancer therapy: lessons from the first decade. Clin
Cancer Res. 14:1649–1657. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rajkumar SV, Richardson PG, Hideshima T
and Anderson KC: Proteasome inhibition as a novel therapeutic
target in human cancer. J Clin Oncol. 23:630–639. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lee GY, Haverty PM, Li L, et al:
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential
cancer driver genes. Cancer Res. 74:3114–3126. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Munkacsy G, Abdul-Ghani R, Mihaly Z, et
al: PSMB7 is associated with anthracycline resistance and is a
prognostic biomarker in breast cancer. Br J Cancer. 102:361–368.
2010. View Article : Google Scholar :
|
|
36
|
Dar AA, Goff LW, Majid S, Berlin J and
El-Rifai W: Aurora kinase inhibitors-rising stars in cancer
therapeutics? Mol Cancer Ther. 9:268–278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mehra R, Serebriiskii IG, Burtness B,
Astsaturov I and Golemis EA: Aurora kinases in head and neck
cancer. Lancet Oncol. 14:e425–e435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bonci D, Coppola V, Musumeci M, et al: The
miR-15a-miR-16-1 cluster controls prostate cancer by targeting
multiple oncogenic activities. Nat Med. 14:1271–1277. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang H, Zuo Z, Lu X, Wang L, Wang H and
Zhu Z: MiR-25 regulates apoptosis by targeting Bim in human ovarian
cancer. Oncol Rep. 27:594–598. 2012.
|
|
41
|
Soon PS, Tacon LJ, Gill AJ, et al: miR-195
and miR-483-5p identified as predictors of poor prognosis in
adrenocortical cancer. Clin Cancer Res. 15:7684–7692. 2009.
View Article : Google Scholar : PubMed/NCBI
|
